Abiopharma

🔍 Sit Roger J (Director)

Company: HUNTINGTON BANCSHARES INC /MD/ (HBAN)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 9,320 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 205,614.54 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By Richard A. Sit Trust | shares_owned_after: 22,921.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By Sit Investment Associates | shares_owned_after: 152,572.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 4,713.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: Director Deferred Compensation Plan | shares_owned_after: 48,169.22 | Footnotes: F2

Footnotes:

• F1: An award of deferred stock units - the underlying shares are deliverable to the Reporting Person six months following separation from service as a director.
• F2: The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities.